Hepatosteatosis and hepatic insulin resistance are blunted by argirein, an anti-inflammatory agent, through normalizing endoplasmic reticulum stress and apoptosis in diabetic liver. (Q51016955)
Jump to navigation
Jump to search
scientific article published on 25 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hepatosteatosis and hepatic insulin resistance are blunted by argirein, an anti-inflammatory agent, through normalizing endoplasmic reticulum stress and apoptosis in diabetic liver. |
scientific article published on 25 March 2013 |
Statements
1 reference
Hepatosteatosis and hepatic insulin resistance are blunted by argirein, an anti-inflammatory agent, through normalizing endoplasmic reticulum stress and apoptosis in diabetic liver. (English)
1 reference
Fang-Hong Shi
1 reference
You Wu
1 reference
De-Zai Dai
1 reference
Xiao-Dong Cong
1 reference
Yu-Mao Zhang
1 reference
Yin Dai
1 reference
25 March 2013
1 reference
65
1 reference
6
1 reference
916-927
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference